Please assess the completion status of the following clinical trial:

Trial Title: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects diagnosed with type 2 diabetes mellitus and treated with either diet or single oral drug therapy~* Diet treated subjects: 7.5% \< HbA1c \< 10%~* Single oral drug therapy subjects: 7.0% \< HbA1c \< 9.5%~* Body Mass Index (BMI): max 40 kg/m\^2~Exclusion Criteria:~* Subjects treated with thiazolidinediones or insulin~* Subjects with any serious medical conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).